Yubo International Biotech Ltd (YBGJ) › Cash & EquivalentsYubo International Biotech Ltd (YBGJ) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2010: $6.0K2011: $7.0K2012: $7.0K2013: $12.0K2014: $8.0K2015: $12.0K2016: $11.0K2017: $1.0K2018: $2.0K2019: $1.3K2020: $1.38M2021: $27.5K2022: $18.2K2023: $6.4K2024: $7.0K2025: $8.1K$8.1K2010Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.1K+14.9%2024$7.0K+10.3%2023$6.4K-65.1%2022$18.2K-33.8%2021$27.5K-98.0%2020$1.38M+109450.2%2019$1.3K-36.9%2018$2.0K+100.0%2017$1.0K-90.9%2016$11.0K-8.3%2015$12.0K+50.0%2014$8.0K-33.3%2013$12.0K+71.4%2012$7.0K+0.0%2011$7.0K+16.7%2010$6.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share